SEARCH

SEARCH BY CITATION

References

  • 1
    Office of Population Censuses and Surveys. Mortality statistics—accidents and violence. Series DH4, no. 15 (Table 10). London : HMSO, 1989.
  • 2
    Hughes RD, Wendon J, Gimson AES. Acute liver failure. Gut 1991; 31(Suppl.): S8691.
  • 3
    Meredith TJ, Prescott LF, Vale JA. Why do patients still die from paracetamol poisoning British Medical Journal 1986; 293: 3456.
  • 4
    Harrison PM, O'Grady JG, Keays RT, Alexander GJM, Williams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. British Medical Journal 1990; 301: 9646.
  • 5
    Nonsteroidal anti-inflammatory antipyretic analgesics.In: Clark WG, Brater DC, Johnson AR, Comps. Goth's medical pharmacology, 13th edn. St Louis : Mosby, 1992: 3657.
  • 6
    Tredger JM, Davis M. Drug metabolism and hepatoxicity. Gut, 1991; 31(Suppl.): S349.
  • 7
    Prescott LF, Illingworth RN, Critchley JAJH, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning. British Medical Journal 1979; 2: 1097100.
  • 8
    Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the National Multicentre Study (1976 to 1985). New England Journal of Medicine 1988; 319: 115762.
  • 9
    O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 43945.
  • 10
    Prescott LF. Treatment of severe acetaminophen poisoning with intravenous acetylcysteine. Archives of International Medicine 1981; 141: 3869.
  • 11
    Harrison PM, Keays R, Bray GP, Alexander GJM, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet 1990; 335: 15723.
  • 12
    Keays R, Harrison PM, Wendon JA, Forbes A, Gove C, Alexander GJM, Williams R. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. British Medical Journal 1991; 303: 10269.
  • 13
    Woodhouse P, Keatinge WR, Coleshaw SRK. Factors associated with hypothermia in patients admitted to a group of inner city hospitals. Lancet 1989; 2: 12015.
  • 14
    Vickers MD, Morgan M, Spencer PSJ. Drugs in anaesthetic practice. London : Butterworth-Heineman, 1991: 17982.
  • 15
    Sessler DI. Temperature monitoring. In: MillerRD, ed. Anesthesia, 3rd edn. New York : Churchill Livingstone, 1990: 1235.
  • 16
    Reuler JB. Hypothermia: pathophysiology, clinical settings, and management. Annals of Internal Medicine 1978; 89: 51927.
  • 17
    Schaller MD, Fischer AP, Perret CH. Hyperkalemia: a prognostic factor during acute severe hypothermia. Journal of the American Medical Association 1990; 264: 18425.
  • 18
    Bernhard WF, McMurrey JD, Ganong WF, Lennihan R. The effect of hypothermia on the peripheral serum levels of free 17-hydroxycorticoids in the dog and man. Annals of Surgery 1956; 143: 2105.